Similar Articles for PMID: 8733954

Year	Number of Results
1927	1
1969	1
1977	1
1980	1
1983	2
1984	5
1985	2
1986	2
1987	4
1989	5
1990	11
1991	7
1992	15
1993	24
1994	42
1995	25
1996	23
1997	38
1998	12
1999	19
2000	18
2001	10
2002	16
2003	8
2004	11
2005	10
2006	16
2007	7
2008	8
2009	11
2010	19
2011	16
2012	13
2013	14
2014	9
2015	9
2016	5
2017	3
2018	4
2019	3
2020	3

1

Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.

Bruening R, Kwong KK, Vevea MJ, Hochberg FH, Cher L, Harsh GR 4th, Niemi PT, Weisskoff RM, Rosen BR. Bruening R, et al. AJNR Am J Neuroradiol. 1996 May;17(5):831-40. AJNR Am J Neuroradiol. 1996. PMID: 8733954 Free article.

2

Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.

Chang KH, Ra DG, Han MH, Cha SH, Kim HD, Han MC. Chang KH, et al. AJNR Am J Neuroradiol. 1994 Sep;15(8):1413-9; discussion 1420-3. AJNR Am J Neuroradiol. 1994. PMID: 7985558

3

Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.

Schmainda KM, Rand SD, Joseph AM, Lund R, Ward BD, Pathak AP, Ulmer JL, Badruddoja MA, Krouwer HG. Schmainda KM, et al. AJNR Am J Neuroradiol. 2004 Oct;25(9):1524-32. AJNR Am J Neuroradiol. 2004. PMID: 15502131 Free article.

4

Measurement of cerebral blood volume via the relaxing effect of low-dose gadopentetate dimeglumine during bolus transit.

Hackländer T, Reichenbach JR, Hofer M, Mödder U. Hackländer T, et al. AJNR Am J Neuroradiol. 1996 May;17(5):821-30. AJNR Am J Neuroradiol. 1996. PMID: 8733953 Free article.

5

Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR 4th, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG. Lev MH, et al. AJNR Am J Neuroradiol. 2004 Feb;25(2):214-21. AJNR Am J Neuroradiol. 2004. PMID: 14970020 Free article.

6

Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.

Wessbecher FW, Maravilla KR, Dalley RW. Wessbecher FW, et al. AJNR Am J Neuroradiol. 1991 Jul-Aug;12(4):675-9. AJNR Am J Neuroradiol. 1991. PMID: 1882743

7

Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin.

Cha S, Knopp EA, Johnson G, Litt A, Glass J, Gruber ML, Lu S, Zagzag D. Cha S, et al. AJNR Am J Neuroradiol. 2000 May;21(5):881-90. AJNR Am J Neuroradiol. 2000. PMID: 10815664 Free article.

8

Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.

Mihara F, Gupta KL, Righi AM. Mihara F, et al. Radiat Med. 1994 Sep-Oct;12(5):209-12. Radiat Med. 1994. PMID: 7863024

9

Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not.

Boxerman JL, Schmainda KM, Weisskoff RM. Boxerman JL, et al. AJNR Am J Neuroradiol. 2006 Apr;27(4):859-67. AJNR Am J Neuroradiol. 2006. PMID: 16611779 Free article.

10

Comparison of lesion enhancement on spin-echo and gradient-echo images.

Chappell PM, Pelc NJ, Foo TK, Glover GH, Haros SP, Enzmann DR. Chappell PM, et al. AJNR Am J Neuroradiol. 1994 Jan;15(1):37-44. AJNR Am J Neuroradiol. 1994. PMID: 8141064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed